160 related articles for article (PubMed ID: 1697401)
21. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.
Keating MJ; Kantarjian H; Talpaz M; Redman J; Koller C; Barlogie B; Velasquez W; Plunkett W; Freireich EJ; McCredie KB
Blood; 1989 Jul; 74(1):19-25. PubMed ID: 2473795
[TBL] [Abstract][Full Text] [Related]
22. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
Hiddemann W; Rottmann R; Wörmann B; Thiel A; Essink M; Ottensmeier C; Freund M; Büchner T; van de Loo J
Ann Hematol; 1991 Jul; 63(1):1-4. PubMed ID: 1715191
[TBL] [Abstract][Full Text] [Related]
23. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary tuberculosis after fludarabine for chronic lymphocytic leukaemia.
Ghosh K; Sivakumaran M; Murphy P; Chapman CS
Natl Med J India; 1995; 8(6):294-5. PubMed ID: 8520454
[No Abstract] [Full Text] [Related]
25. A loading dose/continuous infusion schedule of fludarabine phosphate in chronic lymphocytic leukemia.
Puccio CA; Mittelman A; Lichtman SM; Silver RT; Budman DR; Ahmed T; Feldman EJ; Coleman M; Arnold PM; Arlin ZA
J Clin Oncol; 1991 Sep; 9(9):1562-9. PubMed ID: 1714949
[TBL] [Abstract][Full Text] [Related]
26. Central nervous system toxicity of fludarabine phosphate.
Chun HG; Leyland-Jones BR; Caryk SM; Hoth DF
Cancer Treat Rep; 1986 Oct; 70(10):1225-8. PubMed ID: 2428492
[TBL] [Abstract][Full Text] [Related]
27. Fludarabine monophosphate in refractory B-chronic lymphocytic leukemia: maintenance may be significant to sustain response.
Angelopoulou MA; Poziopoulos C; Boussiotis VA; Kontopidou F; Pangalis GA
Leuk Lymphoma; 1996 Apr; 21(3-4):321-4. PubMed ID: 8726414
[TBL] [Abstract][Full Text] [Related]
28. Lysis pneumonopathy associated with the use of fludarabine phosphate.
Crowley JJ; Knight L; Charan N
West J Med; 1994 Dec; 161(6):597-9. PubMed ID: 7531920
[No Abstract] [Full Text] [Related]
29. Infectious complications of purine analog therapy.
Samonis G; Kontoyiannis DP
Curr Opin Infect Dis; 2001 Aug; 14(4):409-13. PubMed ID: 11964857
[TBL] [Abstract][Full Text] [Related]
30. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
Robertson LE; Keating MJ
Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
[No Abstract] [Full Text] [Related]
31. [Pneumocystis carinii pneumonia in renal transplant recipients treated with cyclosporin].
Kim CJ; Pak K; Wakabayashi Y; Ishida A; Arai Y; Konishi T; Kounami T; Tomoyoshi T; Sako H; Okino K
Hinyokika Kiyo; 1989 Apr; 35(4):653-9. PubMed ID: 2544088
[TBL] [Abstract][Full Text] [Related]
32. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
Binet JL
Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
[TBL] [Abstract][Full Text] [Related]
33. Activity of fludarabine monophosphate in patients with advanced mycosis fungoides: a Southwest Oncology Group study.
Von Hoff DD; Dahlberg S; Hartstock RJ; Eyre HJ
J Natl Cancer Inst; 1990 Aug; 82(16):1353-5. PubMed ID: 1696322
[No Abstract] [Full Text] [Related]
34. Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine.
Sanders C; Perez EA; Lawrence HJ
Am J Hematol; 1992 Apr; 39(4):314-5. PubMed ID: 1553963
[No Abstract] [Full Text] [Related]
35. Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.
Sorensen JM; Vena DA; Fallavollita A; Chun HG; Cheson BD
J Clin Oncol; 1997 Feb; 15(2):458-65. PubMed ID: 9053466
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroid responsive fludarabine pulmonary toxicity.
Stoica GS; Greenberg HE; Rossoff LJ
Am J Clin Oncol; 2002 Aug; 25(4):340-1. PubMed ID: 12151960
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia.
Foran JM; Oscier D; Orchard J; Johnson SA; Tighe M; Cullen MH; de Takats PG; Kraus C; Klein M; Lister TA
J Clin Oncol; 1999 May; 17(5):1574-9. PubMed ID: 10334546
[TBL] [Abstract][Full Text] [Related]
38. Fludarabine in chronic leukaemia.
Astrow AB
Lancet; 1996 May; 347(9013):1420-1. PubMed ID: 8676619
[No Abstract] [Full Text] [Related]
39. Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population.
Perkins JG; Flynn JM; Howard RS; Byrd JC
Cancer; 2002 Apr; 94(7):2033-9. PubMed ID: 11932906
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system toxicity with fludarabine.
Merkel DE; Griffin NL; Kagan-Hallet K; Von Hoff DD
Cancer Treat Rep; 1986 Dec; 70(12):1449-50. PubMed ID: 2431775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
